Kentaro Watanabe | Author | SciTechnol | Endocrinology & Diabete

Kentaro Watanabe Author

KentaroWatanabe@gmail.com

Subjects of specialization
Engineering, International Workshop on ,Nano-Scale Spectroscopy & Nanotechnology (NSS-7), Japan Society for Applied Physics, Kaisei Academy, National Institute for Materials Science, Osaka University, Shinshu University, The Japan Society for Applied Physics, The Japan Society of Applied Physics, Tohoku University, Tokyo Institute of Technology,

Affiliation
Japan Polar Research Association, National Institute of Polar Research, University of Tokyo

Biography

kentaro working in Nano-Scale Spectroscopy & Nanotechnology Nano-Scale Spectroscopy & Nanotechnology (NSS-7), Japan Society for Applied Physics, Kaisei Academy, National Institute for Materials Science, Osaka University, Shinshu University, The Japan Society for Applied Physics, The Japan Society of Applied Physics, Tohoku University, Tokyo Institute of Technology,

Publications

Rapid Communication Subscription

The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome

Author(s):

Tatsuya Suzuki, Masao Hashimoto, Shoko Futami-Suda, Yoshimasa Igari, Kentaro Watanabe, Hiroshi Nakano, Joan Auwerx, Mitsuhiro Watanabe and Kenzo Oba

The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome

Bile acid–binding resins (BABRs) improve hyperglycemia in patients with type 2 diabetes, and the BABR colesevelam has been approved by the U.S. Food and Drug Administration for use as an antihyperglycemic agent. Colestimide (colestilan) is a new type of anion resin that increases the number of hepatic low-density lipoprotein receptors and decreases serum cholesterol levels by promoting the excretion of bile acids and inhibiting the absorption of cholesterol in the intestine; with these changes, the serum level of low-density lipoprotein cholesterol decreases.

DOI: 10.4172/2327-4700.1000101

Abstract HTML PDF Supplementary File